NBT Bank »

Lexicon Pharmaceuticals shares owned by NBT Bank

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by NBT Bank from 13F filings

Historical chart of NBT Bank investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by NBT Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by NBT Bank

Quarter filed Position value Share count Share price at filing
2025-09-30 $14k 10k 1.35
2025-06-30 $9.5k 10k 0.95

More positions owned by NBT Bank

Schwab International Equity ETF (SCHF)
Apple (AAPL)
Vaneck Vectors Etf Tr fallen angel hg (ANGL)
iShares MSCI EAFE Growth Index (EFG)
Schwab U S Small Cap ETF (SCHA)
Exxon Mobil Corporation (XOM)
iShares iBoxx $ High Yid Corp Bond (HYG)
U.S. Bancorp (USB)
Johnson & Johnson (JNJ)
Vanguard Value ETF (VTV)
iShares Barclays 1-3 Year Cred Bd Fd ETF (IGSB)
Microsoft Corporation (MSFT)
Sch Us Mid-cap Etf etf (SCHM)
Raytheon Technologies Corp (RTX)
Caterpillar (CAT)

View all positions for NBT Bank

Top funds holding Lexicon Pharmaceuticals

Artal Group
Siren
FMR
Vanguard Group
Millennium Management
BlackRock
Citadel Advisors
Sessa Capital IM
Atlantic Trust
Geode Capital Management
Caption Management
Susquehanna International
GSA Capital Partners
Charles Schwab Investment Management
State Street Corporation

View all funds holding Lexicon Pharmaceuticals